ATNXQ — Athenex Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.13m
- $74.91m
- $102.82m
Annual cashflow statement for Athenex, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | C2019 December 31st | C2020 December 31st | C2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -129 | -125 | -144 | -160 | -99 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 43.6 | 10.7 | 29.2 | 44.7 | 9.86 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Purchased R&D | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -27.1 | 12.6 | -20.5 | -19 | 11.8 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -109 | -97.5 | -131 | -142 | -75 |
| Capital Expenditures | -3.43 | -13.9 | -8.84 | -2.61 | -2.06 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -45.5 | 21.4 | -110 | 108 | 60 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -49 | 7.5 | -119 | 105 | 57.9 |
| Financing Cash Flow Items | -7.51 | -1.1 | -17.1 | -0.274 | -14.5 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 169 | 167 | 209 | 2.46 | 1.56 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 10.5 | 77.9 | -41.6 | -34.4 | -16.1 |